FY2029 Earnings Estimate for RCUS Issued By Wedbush

Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Stock analysts at Wedbush issued their FY2029 earnings estimates for shares of Arcus Biosciences in a research report issued to clients and investors on Tuesday, February 18th. Wedbush analyst R. Driscoll forecasts that the company will earn $3.03 per share for the year. Wedbush has a “Outperform” […]

Leave a Reply

Your email address will not be published.

Previous post Asset Management One Co. Ltd. Purchases 4,479 Shares of Vipshop Holdings Limited (NYSE:VIPS)
Next post Tactile Systems Technology (NASDAQ:TCMD) Downgraded to “Neutral” Rating by B. Riley